Abstract: New novel derivatives
Introduction
Imidazole derivetives possess a broad spectrum of pharmalogical activities such as anticonvulsant, Antiparkinson , monoamine oxidase (MAO) inihibitory activity, anti-bacterial, anti-fungul activity, it also function as dyestuff, catalyst, polymerizing agents, drugs, herbicides and fungicides [1] [2] [3] . Imidazole derivatives are valuable vasodialating and vasoconstructing drugs.
The chemistry of phosphorus heterocyclic compounds containing nitrogen has pioneered the application of combinatorial techniques to the development of new pharmaceutical materials with novel properties. Organophosphorus compounds possess significant biological activity against broad spectrum of bacteria, pets, virus, fungicides and plant growth regulators. The organophosphorus heterocyclic compounds chemistry received much attention of chemists in past two decades due to their wide range of applications in the field of the agriculture, medicine and industry. Some organophosphorus compounds have been described in the literature as inhibitors of bacterial, herbicides, insecticides, pesticides, anti-fungal agents, anti-HIV, anti-cancer, anti-viral and anti-inflammatory [4] [5] [6] [7] [8] [9] [10] .
A good deal of importance was given to dioxaphosphepino ureas / carboxamides and their derivatives in the field of organophosphorus heterocyclic chemistry due to their unique biological applications [11] . In view of the above observations, we synthesized Imidazole possessing dioxaphosphepino ureas / carboxamides and screening for possible biological and pharmacological activities.
II. Experimental Section
All the chemicals used in the present investigation were purchased from Sigma-Aldrich Chemicals company, Inc. USA. And used without further purification. TLC was performed on aluminium sheet of silica gel 60F254, E-Merk, Germany using iodine as visualizing agent. Melting point were determined in open capillary tubes on Mel-Temp apparatus and are uncorrected. Column chromatography was performed on silica gel with different solvent systems as eluents to afford the pure compound. The IR Spectra were recorded as KBr pellets on Perkin-Elmer 1000 units, instruments. All 1H and 13 C-NMR spectra were recorded on a Varian XL-300 spectrometer operating at 400MHz for 1 
Preparation of Intermediates: 1.1 Synthesis of phenyl phosphorodichloridates 6(a-c) [12]:
Phosphorus oxychloride (15.3 gr, 0.1mole) in dry benzene (60 ml) was taken into three-necked flask (500 ml) equipped with dropping funnel and reflux condenser fitted with a calcium chloride guard tube. The flask was heated and stirred by means of hot plate -cum -magnetic stirrer. To this dry triethyl amine (10.1 gr, 0.1 mole) and dry benzene (50 ml) were added slowly and the reaction mixture was stirred for 30 minutes. To this mixture, freshly distilled phenol (9.4 gr, 0.1 mole) in dry benzene (60 ml) was added drop wise through the dropping funnel. The addition took about thirty minutes and whole reaction mixture was refluxed with vigorous stirring for 10 hours. The reaction mixture was cooled and the solid tri ethylamine -hydrochloride was filtered off. The solvent from the filtrate was removed under reduced pressure in a rota evaporator. The dark brown liquid remained, was subjected to fractional distillation and the major product distilling at 118-124 0 C / 11mm was collected as colourless glassy viscous liquid (8.3 gr, 40%).
Other substituted phenyl phosphorodichlorates 6(a-c) were prepared by the same procedure [13] by reacting equimolar quantities of phosophorous oxychloride and respective substituted phenols in benzene in the presence of tri ethylamine. The data of these aryl phosphorodichloridates are given in Table -1.   Table- o C under nitrogen atmosphere. After the completion of the reactionas indicated by TLC, the solvent was removed under reduced pressure to get crude 1-(isocyanato methyl) -6, 6 -dimethyl-4, 8 -dihydro -1H - [1, 3] dioxepino [5, 6-d] imidazole (2). The crude product was purified by column chromatography (60-120 mesh silica gel, eluent: 10 % EtoAc-pet ether), which was recrystallized using dichloromethane and n-hexane, mp 139-141 o C, yield 70%. To the solution of isocyanate (2) (1eq), in aniline (3a) (10 times) dissolved in toluene (10mL) was stirred -15 o C was refluxed for 16 hours. After completion of the reaction as indicated by TLC, solvent was evaporated under vacuum to give crude residue, purified by column chromatography (60-120 mesh silica gel, eluent: 30% EtoAc-pet ether). Finally the product compound 1-(6, 6-dimethyl-4, 8-dihydro-1H- [1, 3] dioxepino [5, 6-d] imidazole-1-yl) methyl) -3 -phenyl urea (4a) was purified from aqueous dimethyl formamide with m p 166-168 o C, yield 65%. The similar procedure was adopted to synthesise [5, 6-d] imidazole (2) with p-toluidine (3b), 4-methoxyaniline (3c) and 4-chloroaniline (3d) respectively. The isopropylidenation of 1, 2-diols was carried out by a procedure as reported in the literature [15] . A suspension of the 1-(6, 6-dimethyl-4, 8-dihydro-1H- [1, 3] dioxepino [5, 6-d] imidazole-1-yl) methyl) -3-phenyl urea (4a) (1 m mol) in dry acetone and to this 5 mol % of phosphotungstic acid was added and the reaction mixture was stirred at room temperature under nitrogen atmosphere for 1 hour The progress of the reaction was monitored by TLC using cyclohexane and ethyl acetate (7:3) solvent mixture as mobile phase. After completion of the reaction, the solvent was removed under reduced pressure. The residue was extracted with dichloromethane (320 ml) and water and the combined organic layer was dried with Na 2 SO 4 and concentrated in vacuum to give the crude product. The crude product was purified by column chromatography on silica gel (60-120 mesh) with 30% ethyl acetate in cyclohexane as an eluent. The m p of (5a) was 182- A solution of 4-chlorophenyl phosphorodichloridate (6a) (0.002 mole) in 25 ml of dry toluene was added drop wise over a period of 20 minutes to a stirred solution of 1-((4, 5-bis (hydroxyl methyl)-1H-imidazole-1-yl) methyl)-3-phenyl urea (5a) (0.002mole) and triethylamine (0.004mole) in 30 ml of dry toluene and 10ml of tetrahydrofuran at 5 0 c. After completion of the addition, the temperature of the reaction mixture was slowly raised to room temperature and stirred for 2 hours. Later the reaction mixture was heated to 50-60 O C and maintained for 4 hours with stirring. The completion of the reaction was monitored by TLC analysis. Triethyl amine hydrochloric acid was filtered from mixture and solvent was removed under reduced pressure. The residue was washed with water and then recrystallized from aqueous 2-propanol to get pure compound 1- H-NMR, 13 C-NMR, 31 P-NMR and analytical data was shown in the Table 1 .2-1.6.
Synthesis of N-((6, 6-dimethyl-4, 8-dihydro-1H-[1, 3] dioxepino [5, 6-d] imidazole-1-yl) methyl) morpholine-4-carboxamide / piperidine-1-carboxamide / 4 -methyl piperazine-1-carboxamide 9(a-c):
To the solution of isocyanate (2) (1eq), in morpholine (8a) (10 times) dissolved in toluene (10mL) was added and heated -15 o C, the reaction mixture was refluxed for 16 hours. After completion of reaction as indicated by TLC solvent was evaporated under vacuum to give crude residue, purified by column chromatography (60-120 mesh silica gel, eluent: 30% EtoAc-pet ether) solvent was used as an eluent. Finally the product N-
morpholine -4 -carboxamide (9a) was purified from aqueous dimethyl formamide. Yield 65%, m p 139-142 0 C. The similar procedure was adopted to synthesise 9(b-c) by
with piperidine (8b) and 1-methylpiperazine (8c) respectively.
Synthesis of N-((4, 5-bis (hydroxyl methyl)-1H -imidazole-1-yl) methyl) morpholine-4-carboxamide / piperidine-1-carboxamide / 4 -methyl piperazine-1-carboxamide 10(a-c):
The isopropylidenation of 1, 2-diols was carried out by a procedure as reported in the literature 27 . A suspension of the N-( (6, 6- 
morpholine-4-carboxamide (9a) (1 m mol) in dry acetone and to this 5 mol % of phosphotungstic acid was added and the reaction mixture was stirred at room temperature under nitrogen atmosphere for 1 hour The progress of the reaction was monitored by TLC using cyclohexane and ethyl acetate (7:3) solvent mixture as a mobile phase. After completion of the reaction, the solvent was removed under reduced pressure. The residue was extracted with dichloromethane (320 ml) and water and the combined organic layer was dried with Na 2 SO 4 and concentrated in vacuum to give the crude product. The crude product was purified by column chromatography on silica gel (60-120 mesh) with 30% ethyl acetate in cyclohexane as an eluent. The m p of (10a) was 123-126 0 C with yield of 65 %. The similar procedure was adopted to synthesise 10(b-c) from 8(b-c).
Synthesis of N-((6 -(4-chlorophenoxy) / (4-bromophenoxy) / (4-nitrophenoxy) -6 -oxido -4, 8-dihyro -1H -[1, 3, 2] dioxaphophepino [5, 6-d] imidazole-1-yl-) methyl) morpholine -4 -carboxamide / piperidine -1 -carboxamide / 4-methyl piperazine -1 -carboxamide 11(a-i):
A solution of 4-chlorophenyl phosphorodichloridate (6a) (0.002 mole) in 25 ml of dry toluene was added drop wise over a period of 20 minutes to a stirred solution of N-((4, 5-bis (hydroxyl methyl)-1H -imidazole-1-yl) methyl) morpholine-4-carboxamide (10a) (0.002mole) and triethylamine (0.004 mole) in 30 ml of dry toluene and 10ml of tetrahydrofuran at 5 0 C. After completion of the addition, the temperature of the reaction mixture was slowly raised to room temperature and stirred for 2 hours. Later the reaction mixture was heated to 50-60 O C and maintained for 4 hours with stirring. The completion of the reaction was monitored by TLC analysis. Triethyl amine hydrochloride was filtered from reaction mixture and solvent was removed under reduced pressure. The residue was washed with water and then recrystallized from aqueous 2-propanol to get pure compound N-((6 -(4-chlorophenoxy) -6 -oxido -4,
The similar procedure was adopted to synthesise 11(b-i) by the reaction between 10(b-c) with 4 -chlorophenyl phosphorodichloridate (6a), 4 -bromophenyl phosphorodichloridate (6b) and 4 -nitrophenyl phosphorodichloridate (6c). Spectral, Physical and analytical data for the compounds: Table I .2: The IR (KBr) spectra of 1-((6-(4-chlorophenoxy) / (4-bromophenoxy) / (4-nitrophenoxy)-6-oxido-4, 
Biological activity
The antimicrobial activity [16] of these newly synthesized compounds was performed according to disc diffusion method, as recommended by the National Committee for Clinical Laboratory. The synthesised compounds were used at the concentration of 250μg/ml DMF as a solvent [17] .
Anti-bacterial activity
The antibacterial activity of Imidazole Ureas / Carboxamides containing Dioxaphospholanes 7(a-l) and 11(a-i) were screened against the Staphylococcus aureus and Bacillus cerus (gram positive) and Escherichia coli, Pseudomonasaeruginosa (gram negative) organisms. Most of the compounds exhibited good antibacterial activity against both bacteria. The presence of nitro (7j, 7k) and (11g, 11i), chloro (7c, 7d) and (11a, 11c) and bromo (7h, 11d) were showed more activity than other substituted compounds. Here Amoxicillin is tested as reference compound to compare the activity. The anti-bacterial activity was shown in the Table 1.12  Table I .12: Anti-bacterial activity (Diameter zone of Inhibition in mm) of compounds of 7(a-l) and 11(a-i) (250 µg/ml):
Anti-fungal activity
Antifungal activity of Imidazole Ureas / Carboxamides containing Dioxaphospholanes 7(a-l) and 11(ai) were screened against Aspergillus niger and Candida albicans. Most of the compounds exhibit good antifungal activity against both fungai. Most of the compounds exhibit good antifungal activity against both fungai. The presence of nitro (7j,7k) and (11g, 11i) chloro (7c, 7d) and (11a, 11c) and bromo (7h, 11d) were showed more activity than other substituted compounds. Here Ketoconazole is tested as reference compound to compare the activity. The anti-fungalactivity was shown in the Table 1.13. Table I .13: Anti-bacterial activity (Diameter zone of Inhibition in mm) of compounds of 7(a-l) and 11(a-i) (250 µg/ml):
IV.

Conclusions
The newly synthesized compounds Imidazole Ureas / Carboxamides containing Dioxaphospholanes derivatives 7(a-l) and 11(a-i) were found to be active in the study of anti-bacterial and anti-fungal activity. It can be concluded that this class of compounds certainly holds great promise towards the pursuit to discover novel classes of antimicrobial agents.
